Alastair V. Ferguson
Queen's University
192 Papers
2.7K Citations
Alastair V. Ferguson is an academic researcher from Queen's University. The author has contributed to research in topics: Subfornical organ & Hypothalamus. The author has an hindex of 53, co-authored 192 publications. Previous affiliations of Alastair V. Ferguson include University of Manitoba.
Chat about Author
Papers
The paraventricular nucleus of the hypothalamus – a potential target for integrative treatment of autonomic dysfunction
TL;DR: Data is presented which suggests that the PVN plays significant and essential roles in integrating multiple sources of afferent input and sculpting an integrated autonomic output by concurrently modifying the excitability of multiple output pathways.
300
The Area Postrema: A Brain Monitor and Integrator of Systemic Autonomic State
TL;DR: The area postrema is not simply a conduit through which signals flow into the brain, but it is now being recognized as the initial site of integration for these signals as they enter the circuitry of the central nervous system.
228
The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function
TL;DR: Evidence for potential physiologic roles for the hypocretins/orexins in neuroendocrine and autonomic regulation as a consequence of actions in the dorsal vagal complex, paraventricular nucleus, and pituitary is focused upon.
185
Obestatin acts in brain to inhibit thirst
TL;DR: It is concluded that obestatin does not act in pituitary gland to regulate GH secretion but may act in brain to alter thirst mechanisms, and in rats the effects of obstatin on food intake may be secondary to an action of the peptide to inhibit water drinking.
156
Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ.
TL;DR: Initial and later components of the biphasic pressor response elicited by electrical stimulation of SFO were significantly attenuated by losartan, but unaffected by the AT2 receptor antagonist, PD123319, and the short latency increase in mean arterial pressure was 16.6 +/- 2.6 mmHg.
134